Bulletin
Investor Alert

New York Markets After Hours

Biohaven Pharmaceutical Holding Co. Ltd.

NYS: BHVN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204337507/composite

$

63.16

Change

0.00 0.00%

Volume

Volume 2,807

Sep 29, 2020, 4:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204337507/composite

Today's close

$ 62.27

$ 63.16

Change

+0.89 +1.43%

Day low

Day high

$61.50

$63.94

Open
Open: 62.07

52 week low

52 week high

$26.56

$78.75

Open

Market cap

$3.72B

Average volume

491,043

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-11.04

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bhvn

MarketWatch News on BHVN

  1. Biohaven Pharmaceutical stock price target raised to $94 from $74 at Wedbush

    7:09 a.m. June 18, 2020

    - Tomi Kilgore

  2. Biohaven Pharmaceutical stock price target raised to $85 from $53 at Mizuho

    6:36 a.m. June 10, 2020

    - Tomi Kilgore

  3. Biohaven's investigational anxiety drug fails in trial

    9:10 a.m. Feb. 10, 2020

    - Jaimy Lee

  4. Biohaven Pharmaceutical started at outperform with $75 stock price target at Wedbush

    8:31 a.m. Nov. 22, 2019

    - Tomi Kilgore

  5. Facebook Stock Rises as the Dow Climbs Higher

    9:35 a.m. June 18, 2019

    - Barron's Online

  6. These 6 biotech stocks are promising takeover targets

    1:21 p.m. May 2, 2019

    - Michael Brush

  7. Why Amgen Should Buy Alexion Pharmaceuticals

    3:07 p.m. Feb. 1, 2019

    - Barron's Online

  8. Biohaven shares drop 23% after migraine drug trial results

    9:05 a.m. March 26, 2018

    - Emma Court

  9. Biohaven shares drop 23% after migraine drug trial results

    8:35 a.m. March 26, 2018

    - Emma Court

  10. Biohaven Pharmaceutical's stock plunges 28% premarket after disappointing drug trial results

    9:19 a.m. Oct. 2, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/bhvn

Other News on BHVN

  1. Biohaven Is Still A Bargain On Increasing Nurtec ODT Sales

    4:42 a.m. Aug. 26, 2020

    - Seeking Alpha

  2. Biohaven Pharmaceutical (BHVN) Investor Presentation - Slideshow

    12:40 p.m. Aug. 10, 2020

    - Seeking Alpha

  3. Biohaven (BHVN) Q2 Earnings Beat on Strong Nurtec Uptake

    11:55 a.m. Aug. 10, 2020

    - Zacks.com

  4. Biohaven reports almost $10M in Nurtec sales in Q2

    10:32 a.m. Aug. 10, 2020

    - Seeking Alpha

  5. Biohaven Pharmaceuticals Q2 2020 Earnings Preview

    12:35 p.m. Aug. 9, 2020

    - Seeking Alpha

  6. Early Sales of Eli Lilly's Migraine Drug Disappoint

    11:42 a.m. Aug. 6, 2020

    - GuruFocus.com

  7. Biotech Bonanza - Second Half Outlook

    8:24 a.m. July 28, 2020

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/bhvn

Press Releases on BHVN

  1. Wednesday 9/16 Insider Buying Report: BHVN, FTK

    1:33 p.m. Sept. 16, 2020

    - MarketNewsVideo.com

  2. FDA Granted Pediatric Disease Designation for OXi-4503

    9:11 a.m. Sept. 16, 2020

    - GlobeNewswire

  3. FDA Granted Pediatric Disease Designation for OXi-4503

    7:01 a.m. Sept. 16, 2020

    - GlobeNewswire

  4. Rett Syndrome Therapeutics Market Research and Insights 2020

    1:21 a.m. Aug. 26, 2020

    - Market Insight Reports

  5. Thursday 8/13 Insider Buying Report: BHVN, PMBC

    10:33 a.m. Aug. 13, 2020

    - MarketNewsVideo.com

  6. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.